Norma Adán
Impact in
- Geriatrics and Gerontology top 5%
- Sirtuins and Resveratrol in Medicine
Papers in
-
- Systemic Lupus Erythematosus Research 5
-
- Retinal Development and Disorders 2
- Co-authors
- Carmen Clapp (12 shared papers)Gonzalo Martı́nez de la Escalera (11 shared papers)María G. Ledesma-Colunga (8 shared papers)Stéphanie Thebault (4 shared papers)Nadine Binart (4 shared papers)Fernándo López-Barrera (4 shared papers)Jakob Triebel (3 shared papers)Elena González‐Rey (3 shared papers)
In The Last Decade
Norma Adán
16 papers receiving 462 citations
Peers
Comparison fields: 5 of 79
- Geriatrics and Gerontology 43
- Behavioral Neuroscience 19
- Rheumatology 73
- Endocrinology, Diabetes and Metabolism 72
- Developmental Neuroscience 17
Countries citing papers authored by Norma Adán
This map shows the geographic impact of Norma Adán's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Norma Adán with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Norma Adán more than expected).
Fields of papers citing papers by Norma Adán
This network shows the impact of papers produced by Norma Adán. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Norma Adán. The network helps show where Norma Adán may publish in the future.
Co-authors
The 25 scholars most cited alongside Norma Adán, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 89 | |
| 2 | 2018 | 65 | |
| 3 | 2016 | 46 | |
| 4 | 2014 | 35 | |
| 5 | 2017 | 34 | |
| 6 | 2013 | 32 | |
| 7 | 2016 | 32 | |
| 8 | 2014 | 32 | |
| 9 | 2016 | 22 | |
| 10 | 2021 | 20 | |
| 11 | 2020 | 20 | |
| 12 | 2023 | 14 | |
| 13 | 2022 | 8 | |
| 14 | 2022 | 7 | |
| 15 | 2020 | 6 | |
| 16 | 2014 | 5 |
About Norma Adán
Norma Adán is a scholar working on Rheumatology, Molecular Biology, Hematology, Geriatrics and Gerontology and Ophthalmology, having authored 16 papers that have together received 467 indexed citations. Recurring topics across this work include Systemic Lupus Erythematosus Research (5 papers), Retinal Diseases and Treatments (3 papers), Growth Hormone and Insulin-like Growth Factors (3 papers), Blood Coagulation and Thrombosis Mechanisms (3 papers), Cytokine Signaling Pathways and Interactions (3 papers), Sirtuins and Resveratrol in Medicine (3 papers), Retinal Development and Disorders (2 papers) and Autophagy in Disease and Therapy (2 papers). The work is most often cited by research in Geriatrics and Gerontology (43 citations), Behavioral Neuroscience (19 citations), Rheumatology (73 citations), Endocrinology, Diabetes and Metabolism (72 citations) and Developmental Neuroscience (17 citations). Norma Adán has collaborated with scholars based in Mexico, France and Spain. Frequent co-authors include Carmen Clapp, Gonzalo Martı́nez de la Escalera, María G. Ledesma-Colunga, Stéphanie Thebault, Nadine Binart, Fernándo López-Barrera, Jakob Triebel, Elena González‐Rey, Bibiana Moreno-Carranza and Mario Delgado. Their work appears in journals such as European Journal of Medicinal Chemistry, Journal of Neuroendocrinology, Frontiers in Endocrinology, Frontiers in Immunology and Arthritis Research & Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.